Vitamin E therapy in patients with NASH

[1]  J. Yodoi,et al.  Control of oxidative stress and reduction in biochemical markers by Vitamin E treatment in patients with nonalcoholic steatohepatitis: a pilot study. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

[2]  J. Lavine,et al.  Pediatric initiatives within the Nonalcoholic Steatohepatitis-Clinical Research Network (NASH CNR). , 2003, Journal of pediatric gastroenterology and nutrition.

[3]  G. Tarantino,et al.  Cytokine network during NASH and possible treatment selection , 2003, Hepatology.

[4]  C. McClain,et al.  Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E , 2003, Hepatology.

[5]  L. N. Valenti,et al.  Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease , 2002 .

[6]  A. Terano,et al.  Plasma transforming growth factor‐β1 level and efficacy of α‐tocopherol in patients with non‐alcoholic steatohepatitis: a pilot study , 2001, Alimentary pharmacology & therapeutics.

[7]  H. Tilg,et al.  Cytokines in alcoholic and nonalcoholic steatohepatitis. , 2000, The New England journal of medicine.

[8]  J. Lavine.  Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. , 2000, The Journal of pediatrics.

[9]  V. Rogiers,et al.  Transforming growth factor-β gene expression in normal and fibrotic rat liver , 1997 .

[10]  G. Davis,et al.  Transforming growth factor‐ß1 in chronic hepatitis C , 1997 .